Skip Navigation


QJM Advance Access originally published online on January 31, 2008
QJM 2008 101(5):337-344; doi:10.1093/qjmed/hcm124
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/5/337    most recent
hcm124v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Beynon, R.P.
Right arrow Articles by Ray, S.G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beynon, R.P.
Right arrow Articles by Ray, S.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cardiac involvement in muscular dystrophies

R.P. Beynon and S.G. Ray

From the Cardiology Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK

Address correspondence to Dr R.P. Beynon, Cardiology Department, University Hospital of South Manchester NHS Foundation Trust, Southmoor Road, Wytheneshawe, Manchester M23 9LT, UK. email: rbeynon{at}doctors.org.uk


  Abstract

The muscular dystrophies are a heterogeneous group of conditions with a variable distribution and prognosis. Cardiac complications are common and may significantly alter both quality and quantity of life. Whilst complications are disease specific, many patients will require long-term cardiology follow-up looking for the development of a cardiomyopathic process or conduction problems. Improvements in diagnostic techniques now allow mutation-specific diagnosis to be made in some patients so adequate counselling, management and screening can be put in place for individuals and their families.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.